Masoprocol

CAS No:
500-38-9 Category:
  • #LGM Pharma is a Masoprocol CAS# 500-38-9 API supplier distributor based in the USA. Inquire about DMF, cGMP, price, availability, delivery, purity, and more.
  • #Questions? Call our customer API support number 1-(800)-881-8210.
  • #LGM Pharma offers this active ingredient but not the finished dosage forms.

Product Details:

  • CAS No: 500-38-9
  • AHFC code:
  • Synonyms: Dihydronorguaiaretic acid Masoprocolum [INN-Latin] meso-NDGA meso-Nordihydroguaiaretic acid NDGA Nordihydroguaiaretic acid Nordihydroguairaretic acid
  • ATC Code: L01XX10
  • Chemical Formula: C14H13N3O4S2
  • Molecular Weight: 302.3649
  • Assay/Purity: Typically NLT 98%
  • DrugBank: DB00179 (APRD01084)
  • SMILES: C[C,,H](CC1=CC(O)=C(O)C=C1)[C,H](C)CC1=CC(O)=C(O)C=C1
  • InChl: HCZKYJDFEPMADG-TXEJJXNPSA-N
  • PubChem: 71398
  • IUPAC: 4-[(2S,3R)-3-[(3,4-dihydroxyphenyl)methyl]-2-methylbutyl]benzene-1,2-diol

Additional Details

Indication:
Used for the treatment of actinic keratoses (precancerous skin growths that can become malignant if left untreated).
Pharmacodynamics:
Masoprocol is a novel antineoplastic agent. It is not known exactly how masoprocol works. Laboratory experiments have shown that masoprocol prevents cells similar to the ones found in actinic keratoses from multiplying. Masoprocol was withdrawn from the U.S. market in June 1996.
Mode of Action:
Although the exact mechanism of action is not known, studies have shown that masoprocol is a potent 5-lipoxygenase inhibitor and has antiproliferative activity against keratinocytes in tissue culture, but the relationship between this activity and its effectiveness in actinic keratoses is unknown. Masoprocol also inhibits prostaglandins but the significance of this action is not yet known.
Metabolism:
Toxicity:
Symptoms of overdose or allergic reaction include bluish coloration of skin, dizziness, severe, or feeling faint, wheezing or trouble in breathing.
General Reference:
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk.

API’s From Quality Manufacturers:

  • Cost effective materials based on specific requirements
  • Small quantities for initial research and larger development quantities towards product commercialization

 

  • Technical packages, letters of access to filed DMFs
  • Complete assistance in any regulatory filings
  • Top quality GMP certified manufacturers
  • Have necessary regulatory credentials

 

Related YouTube Videos